These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8285624)

  • 21. Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates.
    Gkentzi D; Kolyva S; Spiliopoulou I; Marangos M; Dimitriou G
    Curr Pediatr Rev; 2016; 12(3):199-208. PubMed ID: 27262336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
    Lowy FD; Chang DS; Lash PR
    Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
    Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
    [No Abstract]   [Full Text] [Related]  

  • 25. Staphylococcus aureus infection of dialysis shunt: absence of synergy with vancomycin and rifampin.
    Tofte RW; Solliday J; Rotschafer J; Crossley KB
    South Med J; 1981 May; 74(5):612-5. PubMed ID: 7244722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of teicoplanin in the treatment of bloodstream infection caused by methicillin-resistant coagulase-negative staphylococci.
    Yamada K; Ueda T; Nakajima K; Ichiki K; Tsuchida T; Otani N; Takahashi Y; Ikeuchi H; Uchino M; Koshiba M; Takesue Y
    J Infect Chemother; 2020 May; 26(5):459-464. PubMed ID: 31870587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Hessen MT; Pitsakis PG; Kaye D
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1143-5. PubMed ID: 2393273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns.
    Gang RK; Sanyal SC; Mokaddas E; Lari AR
    Burns; 1999 Nov; 25(7):640-4. PubMed ID: 10563691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.
    Khatib R; Riederer KM; Held M; Aljundi H
    Scand J Infect Dis; 1995; 27(5):529-32. PubMed ID: 8588150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
    Sinkeler FS; de Haan TR; Hodiamont CJ; Bijleveld YA; Pajkrt D; Mathôt RA
    BMC Pediatr; 2014 Jul; 14():193. PubMed ID: 25066951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
    Daver NG; Shelburne SA; Atmar RL; Giordano TP; Stager CE; Reitman CA; White AC
    J Infect; 2007 Jun; 54(6):539-44. PubMed ID: 17198732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
    Kobasa WD; Kaye KL; Shapiro T; Kaye D
    Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Lucet JC; Herrmann M; Rohner P; Auckenthaler R; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.
    Schaad HJ; Chuard C; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1703-10. PubMed ID: 7985998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
    Krediet TG; Jones ME; Gerards LJ; Fleer A
    Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
    Faville RJ; Zaske DE; Kaplan EL; Crossley K; Sabath LD; Quie PG
    JAMA; 1978 Oct; 240(18):1963-5. PubMed ID: 249793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.